Latest news for Getinge (OTC:GNGBF) Stock

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB

Getinge AB (publ) (GNGBF) Q3 2023 Earnings Call Transcript

Getinge AB (publ) 2023 Q4 - Results - Earnings Call Presentation

Getinge AB's (GNGBF) Q4 2023 Earnings Call Transcript

Nuveen Enhanced Yield U.S. Aggregate Bond ETF declares monthly distribution of $0.0727

Nuveen Enhanced Yield 1-5 Year U.S. Aggregate Bond ETF declares monthly distribution of $0.0663

Getinge AB (publ) Non-GAAP EPS of SEK3.11, revenue of SEK9.91B

Getinge AB (publ) reports Q1 results

Getinge AB (GNGBF) Q1 2024 Earnings Call Transcript

Getinge AB (publ) reports Q2 results

Getinge AB (GNGBF) Q2 2024 Earnings Call Transcript

GNGBF

GNGBY

NUAG

NUSA

Press Releases

Getinge takes a leap forward in cardiovascular surgery with the 510(k) clearance for Vasoview Hemopro 3

Small Cap

Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average

Earnings

Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers

Getinge

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Getinge

News

Latest news for Getinge (OTC:GNGBF) Stock